A Shot to Prevent Cryptococcus Infection
A subunit Cryptococcus vaccine
This project aims to develop a new vaccine to protect people with weakened immune systems, like those with HIV or organ transplants, from a serious fungal infection called cryptococcosis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11124614 on NIH RePORTER |
What this research studies
Cryptococcosis is a severe fungal infection that often leads to meningitis, especially in people with compromised immune systems. Our goal is to create a vaccine using specific parts of the Cryptococcus fungus, called antigens, combined with a booster to strengthen the immune response. We are carefully designing this vaccine to stimulate the body's T helper cells, which are crucial for fighting off this infection. The hope is that this multi-antigen approach will offer broad protection against different strains of the fungus and be effective for diverse human populations.
Who could benefit from this research
Good fit: This research is ultimately for people at higher risk of cryptococcosis, such as those living with HIV, organ transplant recipients, or individuals in areas where the infection is common.
Not a fit: Patients who are not at risk for cryptococcosis or who already have an active infection would not directly benefit from this preventive vaccine.
Why it matters
Potential benefit: If successful, this vaccine could prevent life-threatening cryptococcal meningitis and other severe infections in vulnerable individuals worldwide.
How similar studies have performed: Previous work has shown promising protective results with single antigens in mouse models, suggesting a strong foundation for this multi-antigen approach.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Levitz, Stuart Michael — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Levitz, Stuart Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.